https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:22098 Wed 19 Apr 2023 16:41:23 AEST ]]> Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52166 Wed 04 Oct 2023 10:56:58 AEDT ]]> Exhaled nitric oxide in pulmonary diseases: a comprehensive review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11071 Sat 24 Mar 2018 08:09:44 AEDT ]]> Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:5638 Sat 24 Mar 2018 07:44:01 AEDT ]]> Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48458 Fri 17 Mar 2023 12:07:53 AEDT ]]>